Abiopharma

🔍 FRIES MICHAEL T (Director)

Company: Liberty Global Ltd. (LBTY)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 86,485 shares of Class A Common Shares (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,169,148.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40,623 shares of Class A Common Shares at $12.18 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,128,525.00 | transaction_form_type: 4
• Acquired 86,485 shares of Class C Common Shares (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,079,762.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40,623 shares of Class C Common Shares at $11.91 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,039,139.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Shares (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 8,135.00
• Holds 0 shares of Class C Common Shares (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 25,783.00

Footnotes:

• F1: The shares (subject to applicable tax withholding) were issued to the Reporting Person at the discretion of the Issuer's compensation committee following the completion of the three-year performance period of the Issuer's 2023 Ventures Incentive Plan, which performance period began on January 1, 2023 and ended on December 31, 2025.
• REMARKS: The trading symbols for the Issuer's classes of common shares are LBTYA, LBTYB, and LBTYK.